Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 16;3(2):23.
doi: 10.3390/jcdd3020023.

Vascular Development and Regeneration in the Mammalian Heart

Oscar M Leung  1   2 , Bin Zhou  3   4   5 , Kathy O Lui  6   7
Affiliations
Review

Vascular Development and Regeneration in the Mammalian Heart

Oscar M Leung et al. J Cardiovasc Dev Dis. .

Abstract

Cardiovascular diseases including coronary artery disease are the leading cause of death worldwide. Unraveling the developmental origin of coronary vessels could offer important therapeutic implications for treatment of cardiovascular diseases. The recent identification of the endocardial source of coronary vessels reveals a heterogeneous origin of coronary arteries in the adult heart. In this review, we will highlight recent advances in finding the sources of coronary vessels in the mammalian heart from lineage-tracing models as well as differentiation studies using pluripotent stem cells. Moreover, we will also discuss how we induce neovascularization in the damaged heart through transient yet highly efficient expression of VEGF-modified mRNAs as a potentially therapeutic delivery platform.

Keywords: angiocrine factors; heart regeneration; vascular development; vascular endothelial cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Chien K.R., Zangi L., Lui K.O. Synthetic chemically modified mRNA (modRNA): Toward a new technology platform for cardiovascular biology and medicine. Cold Spring Harb. Perspect. Med. 2015;5:a014035. doi: 10.1101/cshperspect.a014035. - DOI - PMC - PubMed
    1. Lui K.O., Zangi L., Chien K.R. Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA. Stem Cell Res. 2014;13 Pt B:693–704. doi: 10.1016/j.scr.2014.06.007. - DOI - PubMed
    1. World Health Organization Fact Sheets of Cardiovascular Diseases. [(accessed on 1 June 2016)]. Available online: http://www.who.int/mediacentre/factsheets/fs317/en/
    1. Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y., Qyang Y., Bu L., Sasaki M., Martin-Puig S., et al. Multipotent embryonic Isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell. 2006;127:1151–1165. doi: 10.1016/j.cell.2006.10.029. - DOI - PubMed
    1. Paffett-Lugassy N., Singh R., Nevis K.R., Guner-Ataman B., O’Loughlin E., Jahangiri L., Harvey R.P., Burns C.G., Burns C.E. Heart field origin of great vessel precursors relies on nkx2.5-mediated vasculogenesis. Nat. Cell Biol. 2013;15:1362–1369. doi: 10.1038/ncb2862. - DOI - PMC - PubMed

LinkOut - more resources